A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2004
12/01/2004	CN1551914A FAD4, FAD5, FAD5-2 and FAD6, novel fatty acid desaturase family members and uses thereof
12/01/2004	CN1551877A Piperidine derivatives useful as CCR5 antagonists
12/01/2004	CN1551872A Biologically active methylene blue derivatives
12/01/2004	CN1551783A Method for treating multiple myeloma
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004	CN1551766A Lymphocytic activation inhibitor and remedial agent for autoimmune disease
12/01/2004	CN1550233A Skin patch and method for administering testosterone
12/01/2004	CN1177860C Cholenic acid amides and pharmaceutical compositions thereof
12/01/2004	CN1177843C Novel chalcones
12/01/2004	CN1177832C Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
12/01/2004	CN1177830C Benzoheterocycles and their use as MEK inhibitors
12/01/2004	CN1177828C Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
12/01/2004	CN1177821C Matrix metalloprotease inhibitors
12/01/2004	CN1177600C Chinese medicine compound preparation for treating cervical spondylosis, and preparing process thereof
11/2004
11/30/2004	US6825355 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease
11/30/2004	US6825233 Substituted bonzoic acid derivatives, useful for preventing and/or treating tumors, arthritis, and non-malignant skin disorders
11/30/2004	US6825224 Prodrugs of carbamate inhibitors of IMPDH
11/30/2004	US6825221 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
11/30/2004	US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004	US6825200 Substituted dipeptides having nos inhibiting activity
11/30/2004	US6825197 Cyclic GMP-specific phosphodiesterase inhibitors
11/30/2004	US6825190 Protein kinase inhibitors and uses thereof
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	US6825180 Cytokine intracellular signaling inhibitors; antiinflammatory agents
11/30/2004	US6824978 Regulation of endogenous gene expression in cells using zinc finger proteins
11/30/2004	CA2362117C A system for cell-based screening
11/25/2004	WO2004101593A1 5'-modified nucleoside derivative and medicinal use thereof
11/25/2004	WO2004101551A1 Crystal of benzimidazole derivative and process for producing the same
11/25/2004	WO2004101529A1 Nitrogenous heterocyclic compound and medical use thereof
11/25/2004	WO2004101514A1 Cyanofluoropyrrolidine derivative
11/25/2004	WO2004100982A1 C1 inhibitor with short half-life for transient treatment
11/25/2004	WO2004100976A1 Klotho protein, anti-klotho protein antibody and use thereof
11/25/2004	WO2004100959A1 External patch containing estrogen and/or progestogen
11/25/2004	WO2004100924A2 Method of preparing a formulation containing a microdosed active principle
11/25/2004	WO2004091591A3 Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof
11/25/2004	WO2004071416B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/25/2004	WO2003070197A3 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/25/2004	US20040237127 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
11/25/2004	US20040236147 Integrin antagonist; antiinflammatory agents; antiarthritic agents; inflammatory bowel disease; lupus; multiple sclerosis; asthma; psoriasis;antidiabetic agents; cardiovascular disorders
11/25/2004	US20040236135 Preparation and use of alpha-keto phosphonates
11/25/2004	US20040236111 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
11/25/2004	US20040236108 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO); treat an inflammatory disease or condition, related to carbohydrate metabolism, smooth muscle cell function; chemical synthesis
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040236074 Antibacterial treatment of osteoarthritis
11/25/2004	US20040236073 A polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor
11/25/2004	US20040235938 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/25/2004	US20040235936 Analgesics; anesthetics; antiinflammatory agents; central nervous system duisorders; strokes; antiarthritic agents; inflammatory bowel disorders
11/25/2004	US20040235930 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
11/25/2004	US20040235924 antidepressants; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches;drug addition; antiinflammatory agents
11/25/2004	US20040235919 Useful in treating cell proliferative disorders associated with an altered cell cycle dependent kinase activity; cancer, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders
11/25/2004	US20040235896 Certain azacycloalkyl substituted acetic acid derivatives
11/25/2004	US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/25/2004	US20040235870 Protein kinase inhibitors
11/25/2004	US20040235866 Lymphocytic activation inhibitor and remedial agent for autoimmune disease
11/25/2004	US20040235864 Jun kinase inhibitors
11/25/2004	US20040235863 As stimulators for soluble guanylate cyclase and to their use as agents in the therapy of cardiovascular diseases, hypertonicity, thrombo-embolic diseases and ischemia, sexual dysfunction or inflammations and for the treatment of diseases of the central nervous system
11/25/2004	US20040235862 Protein kinase inhibitors
11/25/2004	US20040235858 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
11/25/2004	US20040235849 For therapy and prophylaxis of states of pain
11/25/2004	US20040235845 Use of phosphodiesterase iv inhibitors
11/25/2004	US20040235837 Method for treating fibrotic diseases or other indications IE
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235814 Administering compounds such as 1-[1-methylene-4-(bromo-methylene)phenylene]-4,8,11-tris(diethoxyphosphoryl-1,4,8,11-tetraazacyclotetra-decane to modulate a chemokine receptor
11/25/2004	US20040235808 Administering compounds such as 17 beta -[4-(dimethylamino)-benzoyloxy]-androst-4-en-3-one for modulating a function mediated by the androgen receptor in a tissue selective manner
11/25/2004	US20040235757 Anticarcinogenic and antimetastasis agents; leukemia or Hodgkin's disease.
11/25/2004	US20040235740 Administered as antitumor, antimetastasis, anticarcinogenic and/or wound healing agent; tissue regeneration
11/25/2004	US20040235728 Compositions and methods for treating osteoporosis
11/25/2004	US20040235083 Screening method
11/25/2004	US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004	US20040234993 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
11/25/2004	US20040234575 Medical products comprising a haemocompatible coating, production and use thereof
11/25/2004	US20040234527 Peptides for use as translocation factors
11/25/2004	US20040234524 Anti-osteopontin antibody and use thereof
11/25/2004	US20040234518 Composition, methods and reagents for the synthesis of a soluble form of human PHEX
11/25/2004	DE20221047U1 Serial battery charger including charging section, which includes at least first and second parallel- connected branches has one-way electronic device of very low-impedance when current flows from charging section into battery terminals
11/25/2004	DE10320453A1 Neue Bioisostere von Actinonin New bioisosteres of Actinonin
11/25/2004	CA2525522A1 C1 inhibitor with short half-life for transient treatment
11/25/2004	CA2525442A1 Cyanofluoropyrrolidine derivatives
11/25/2004	CA2524228A1 Method of preparing a formulation containing a microdosed active principle
11/25/2004	CA2523978A1 Crystal of benzimidazole derivative and process for producing the same
11/24/2004	EP1479671A1 Pyrimidinone compounds
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478648A2 Phosphorus-containing compounds uses thereof
11/24/2004	EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004	EP1478631A1 Therapeutic compounds
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478622A1 Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n- 2 n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl -ethylpyrrolidine
11/24/2004	EP1478613A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benz[a]anthracenes for selective effects on estrogen receptors
11/24/2004	EP1478394A2 Polypeptide formulation
11/24/2004	EP1478393A2 Anti-pathogen treatements
11/24/2004	EP1478385A2 Bmp inhibitors for the treatment of spondyloarthropathies
11/24/2004	EP1478369A1 Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
11/24/2004	EP1478366A1 Pharmaceutical combinations of cox-2 inhibitors and opiates
11/24/2004	EP1478359A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
11/24/2004	EP1478358A1 Aryl ureas with angiogenesis inhibiting activity
11/24/2004	EP1478357A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
11/24/2004	EP1478353A1 Sustained release pharmaceutical composition
11/24/2004	EP1478328A2 Bioactive keratin peptides

1 ... 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 ... 820